Arkolith/Insider Trading/DMTK/Form 4/A

Dobak John

Chief Executive Officer, DirectorDermTech, Inc. (DMTK) · full profile →Form 4/A · filed Apr 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2023Sell(S)2K$3.26$5K699K
Mar 9, 2023Grant(A)56K—$0700K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-23-023658) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML